FDA 483 - Alkem Laboratories Limited - July 03, 2026

Rubicon Research Limited, a drug manufacturer in Pithampur, India, received a Form 483 citing significant deficiencies during an FDA inspection. The observations primarily concerned failures in equipment qualification for manufacturing, labeling, and packaging operations. Additionally, the firm lacked established and followed written procedures for equipment cleaning and maintenance, including proper documentation of cleaning activities.